术前CT肌脂肪变与内脏肥胖预测胰腺癌术后早期复发
这项两中心回顾性研究纳入451例可切除胰腺导管腺癌患者,评估术前CT体成分参数与术后早期复发的关系。多因素分析显示肌脂肪变和高内脏脂肪面积是早期复发的独立预后因素。基于此建立的评分系统在训练集与外部验证集中均显示中等到良好的区分度。
要点
- 术前CT报告可加报肌脂肪变和高内脏脂肪面积,提示术后早期复发风险升高。
- 肌脂肪变与载脂蛋白A1、白蛋白、中性粒细胞/淋巴细胞比值相关。
- 评分≥2.5的患者早期复发率显著高于低分组(76% vs 43%)。
核心结论
- 肌脂肪变和高内脏脂肪面积是胰腺导管腺癌术后早期复发的独立预后因素。
- 将体成分分析纳入术后评估可能改善早期复发风险分层。
研究设计与样本
- 回顾性研究,两中心共451例可切除胰腺导管腺癌患者,训练集376例,外部验证集75例。
- 体成分参数包括骨骼肌指数、骨骼肌密度、皮下脂肪面积与密度、内脏脂肪面积与密度。
- 采用Cox比例风险回归识别早期复发的独立预后因素,建立加权评分系统并外部验证。
关键影像表现/征象
- 肌脂肪变表现为术前CT骨骼肌密度降低。
- 高内脏脂肪面积表现为术前CT内脏脂肪组织面积增大。
- 胰周浸润和合并胰腺炎是影像可见的独立早期复发风险因素。
诊断标准与关键数值
- 肌脂肪变预测早期复发的HR为1.65,95%CI为[1.26-2.18],P<0.001。
- 高内脏脂肪面积预测早期复发的HR为1.48,95%CI为[1.09-2.01],P=0.022。
- 评分系统在训练集的AUC为0.724,95%CI为0.677-0.768;外部验证集AUC为0.708,95%CI为0.591-0.807。
- 评分≥2.5的患者早期复发率显著高于评分<2.5的患者(76% vs 43%,P<0.001)。
临床应用与阅片要点
- 阅片时在术前CT上关注骨骼肌密度减低和内脏脂肪面积增大,主动提示术后早期复发风险。
- 术后6个月CT发现骨骼肌密度较基线下降时,可结合炎症指标如中性粒细胞/淋巴细胞比值综合判断。
- 报告可纳入胰周浸润、合并胰腺炎等影像征象,这些也是早期复发的独立危险因素。
局限性
- 回顾性研究设计存在选择偏倚和混杂因素控制局限。
- 术后6个月CT亚组仅129例,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Evidence suggests that body composition is a predictor of poor prognosis in pancreatic ductal adenocarcinoma (PDAC), but its association with early recurrence remains undetermined. This study investigated whether body composition parameters were associated with early recurrence after surgery in patients with resectable PDAC.
MATERIALS AND METHODS: A total of 451 patients (376 in the training cohort, 75 in the external validation cohort) from two centers were retrospectively analyzed. Body composition parameters included skeletal muscle index (SMI) and density (SMD), subcutaneous and visceral adipose tissue (SAT and VAT) area and density. Cox proportional hazards regression was used to identify independent prognostic factors of early recurrence, and a weighted scoring system was developed and externally validated.
RESULTS: Multivariable analysis revealed that concomitant pancreatitis (HR:1.51, 95%CI:[1.02-2.24],P=0.041), peripancreatic infiltration (HR:1.70, 95%CI:[1.25-2.28], P<0.001), tumor grade (III vs. I-II) (HR:1.75, 95%CI:[1.33-2.29], P<0.001), adjuvant chemotherapy/concurrent chemoradiotherapy (CCRT) (HR:0.63, 95%CI:[0.47-0.86], P=0.003), CA19-9>500 U/mL (HR:2.03, 95%CI:[1.49-2.61], P<0.001), and myosteatosis (HR:1.65, 95%CI:[1.26-2.18], P<0.001) and high VAT (HR:1.48, 95%CI:[1.09-2.01], P=0.022) were independent prognostic factors for early recurrence. The scoring system demonstrated moderate to good discrimination in the training cohort (AUC=0.724, 95% CI:0.677-0.768) and external validation cohort (AUC=0.708, 95%CI: 0.591-0.807). Patients with scores ≥2.5 had significantly higher early recurrence rates (76% vs. 43%; P<0.001). SMD was correlated with apolipoprotein A1, albumin and neutrophil-to-lymphocyte ratio (NLR) (all P<0.010). Baseline NLR was independently associated with SMD reduction (P<0.001) in the availability-based subgroup with 6-month postoperative CT (n = 129).
CONCLUSION: Myosteatosis and high VAT were independently associated with early recurrence after surgery. Incorporating body composition analysis into postoperative assessments may improve risk stratification for early recurrence.
引用
- Zhu, Yu, Liu, et al. Myosteatosis and Visceral Adiposity on Preoperative CT are Associated with Early Recurrence in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Acad Radiol. 2026. PMID: 42471256. doi:10.1016/j.acra.2026.06.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。